 DUBLIN, Ireland, May 18, 2022 GLOBE NEWSWIRE -- Avadel Pharmaceuticals plc Nasdaq: AVDL, a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Wednesday, May 25 at 8:30 a.m. E.T. 